A growing number of doctors recommend a daily aspirin to patients who have cardiovascular disease. But many patients still have questions about who should be taking aspirin, and new research about the benefits of aspirin are still being conducted,
This week, “Take Care” speaks with Dr. Charles Hennekens, the world’s leading authority on aspirin research in cardiovascular health. He was the first to demonstrate that aspirin prevents a first heart attack, and the first to discover the life-saving properties of aspirin, both for patients experiencing heart attacks as well as heart attack survivors. He’s held the distinction of being the third most widely cited medical researcher in the world for over a decade.
Click "Read More" to hear our interview with Dr. Charles Hennekens.